 I want to bring someone else into the conversation here. William Fitzsimmons is an advisor to the Transplant Therapeutic Consortium. He spent 29 years in the pharmaceutical industry, so he can tell us a little bit about developing new drugs. And he did help develop some transplant drugs. Some made it to market. Some didn't. Bill, thanks so much for being with us on the show today. Hi, Deborah. It's my pleasure to join you.